Stem Cell Transplant
38
7
9
21
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 38 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
33%
7 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (38)
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
Mosaic Trial for Stem Cell Transplant Recipients
Psychoeducation for AlloHCT Caregivers
Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.
Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
BMT4me: Post-HSCT Medication Adherence mHealth App
Shingrix In Recipients of Allogeneic Transplants
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
mPCST for BMT Patients
Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT
Fertility Protection for Children, Adolescents and Young Adults
Hematopoietic Stem Cell Transplant Survivors Study
Critical Care Outcomes of Hematologic Oncology Patients
Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients
Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation